GERN Investors Have Opportunity to Lead the Geron Corporation Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - GERN

Core Viewpoint - A class action lawsuit has been filed against Geron Corporation for alleged violations of federal securities laws, specifically regarding misleading statements about its revenue outlook and growth potential [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Geron provided false and misleading information to investors, creating an overly optimistic view of the projected revenue and growth related to the launch of Rytelo [2]. - It is alleged that Geron did not disclose that Rytelo lacked necessary patient awareness, which hindered the company's ability to meet the claimed significant unmet need for the drug [2]. Group 2: Investor Participation - Shareholders who purchased Geron's securities between June 7, 2024, and February 25, 2025, are encouraged to contact the DJS Law Group to participate in the class action lawsuit before May 12, 2025 [1][3].